Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Informal Human Milk Sharing: The Experiences and Practices of Informal Human Milk Sharing in Ireland.

Maternal & child nutrition·2026
Same author

Implementing childhood obesity management in Ireland: stakeholder perspectives, priorities and recommendations for practice.

BMC health services research·2026
Same author

Community-based, supervised, group exercise for people living with chronic conditions and multimorbidity: a cohort study.

Age and ageing·2026
Same author

Prioritising and ranking methodological uncertainties in the design, conduct, and analysis of trials aiming to improve health outcomes for those living with multiple long-term conditions: A protocol for a modified Delphi study.

Journal of multimorbidity and comorbidity·2026
Same author

National and International Clinical Guidelines for the Management of Obesity in Adults: A Systematic Review.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2026
Same author

AKT Signaling Differentially Regulates the Expression of Two Evolutionarily Conserved <i>Wnt5a</i> Isoforms in Lung Mesenchymal Cells.

Cells·2026

Related Experiment Videos

Implementing a peer-support intervention for people with type 2 diabetes: a qualitative study.

Gillian Paul1, Karen Keogh, Maureen D'Eath

  • 1Faculty of Nursing and Midwifery, Royal College of Surgeons, Dublin.

Family Practice
|July 10, 2013
PubMed
Summary

Implementing peer support for type 2 diabetes in general practice is feasible. Participants and peer supporters found the intervention valuable, though challenges in meeting attendance require consideration for future research.

Keywords:
Intervention studiesqualitative researchsupport groupstype 2 diabetes mellitus.

Related Experiment Videos

Area of Science:

  • Health Services Research
  • Qualitative Research
  • Patient Support Programs

Background:

  • Type 2 diabetes management requires effective patient support.
  • Peer support interventions show promise in chronic disease management.
  • Understanding implementation experiences is crucial for program success.

Purpose of the Study:

  • To explore the experiences of patients, peer supporters, and practice nurses during the implementation of a peer-support intervention for type 2 diabetes.
  • To identify facilitators and barriers to implementing peer support in a general practice setting.

Main Methods:

  • Qualitative study using focus groups and semi-structured interviews.
  • Framework analysis of transcribed data from 33 intervention participants, 15 peer supporters, and 6 practice nurses.
  • Data collected from participants in a 2-year randomized controlled trial of peer support in type 2 diabetes.

Main Results:

  • Recruitment of peer supporters through general practices was successful.
  • Peer supporters reported satisfaction with training and support, despite initial hesitation.
  • Participants positively received peer-led meetings, appreciating the 'Frequently Asked Questions' component, but desired occasional health professional input.

Conclusions:

  • Peer support interventions are feasible to implement within general practice settings.
  • Key challenges, such as meeting attendance, were identified and need addressing in future research.
  • The study provides insights into optimizing peer support delivery for type 2 diabetes management.